Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Selecta Biosciences, Inc. Company Profile

16:58 EDT 20th April 2014 | BioPortfolio

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta's proprietary Synthetic Vaccine Particle (SVP™) platform creates a new paradigm in vaccine development, enabling completely new therapeutic applications while offering the potential of improved efficacy and safety profiles. Selecta’s fully synthetic engineering of novel vaccines offers a number of compelling benefits, including flexible modular vaccine design and accelerated development timelines using robust manufacturing processes. Selecta’s SVP™ platform technology is flexible to enable diverse vaccines and the company has created targeted antigen-specific Synthetic Vaccine Particles (tSVP™) and targeted antigen-specific tolerogenic Synthetic Vaccine Particles (t2SVP™).


News Articles [472 Associated News Articles listed on BioPortfolio]

Selecta Biosciences, Inc. - Product Pipeline Review - 2013

Recently added to the BioPortfolio report store, Selecta Biosciences, Inc. - Product Pipeline Review - 2013 is a new report from Global Markets Direct published on 2013-12-30. This 27-page report is...

Hot deal to cool immune response

Selecta Biosciences and Sanofi have signed a global collaboration to develop antigen-specific immunotherapies for up to three allergy indications.

Selecta Biosciences Announces Allowance of the First in a Series of Patents on the Induction of Antigen-Specific Immune Tolerance Using Selecta’s Novel Immunotherapies

Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune tolerance treatments, today announced that th...

Apricus Biosciences, Inc.: Apricus Biosciences to Present at the 16th Annual BIO CEO & Investor Conference

SAN DIEGO, 2014-02-04 13:00 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), today announced that Richard Pascoe, Chief ...

Lilly Invests $7.5M in Indiana Biosciences

Will support biosciences research in the state

Apricus Biosciences, Inc.: Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in Belgium

Vitaros(R) Remains on Track for Launch in 2014 SAN DIEGO, 2014-01-23 16:07 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), today a...

Kindred Biosciences reduces to $46 million for IPO

Pet drug developer Kindred Biosciences reduces IPO The weakening biotech IPO market is taking a bite out of pet drug developer Kindred Biosciences Inc.’s planned offering. The one-year-old Burli...

Apricus Biosciences, Inc.: Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in Italy

Vitaros® on Track for European Launch in 2014 Additional Vitaros® Partnerships Expected in 4Q 2013 SAN DIEGO, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus" or the "Company"....

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [29 Associated PubMed Articles listed on BioPortfolio]

China Plans Large Center for PDX Models.

The Chinese Academy of Sciences' Shanghai Institute of Materia Medica will collaborate with Crown Biosciences to build a collection of about 4,000 patient-derived xenograft models that will aid cancer...

Estimation of the Malthusian parameter in an stochastic epidemic model using martingale methods.

Data, on the number of infected, gathered from a large epidemic outbreak can be used to estimate parameters related to the strength and speed of the spread. The Malthusian parameter, which determines...

Implications of salivary protein binding to commensal and pathogenic bacteria.

An important function of salivary proteins is to interact with microorganisms that enter the oral cavity. For some microbes, these interactions promote microbial colonization. For others, these intera...

A Note on Penalized Regression Spline Estimation in the Secondary Analysis of Case-Control Data.

Primary analysis of case-control studies focuses on the relationship between disease (D) and a set of covariates of interest (Y, X). A secondary application of the case-control study, often invoked in...

Sexual selection under parental choice: a revision to the model.

Across human cultures, parents exercise considerable influence over their children's mate choices. The model of parental choice provides a good account of these patterns, but its prediction that male...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Companies [288 Associated Companies listed on BioPortfolio]

Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen...

Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and co...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

BD Biosciences Bioimaging

BD Biosciences Bioimaging gives "sight" to computers, by creating software that captures images from digital cameras and extracts information from those images. We integrate our software into high-per...

More Information about "Selecta Biosciences, Inc." on BioPortfolio

We have published hundreds of Selecta Biosciences, Inc. news stories on BioPortfolio along with dozens of Selecta Biosciences, Inc. Clinical Trials and PubMed Articles about Selecta Biosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selecta Biosciences, Inc. Companies in our database. You can also find out about relevant Selecta Biosciences, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement